Reactions 1680, p243 - 2 Dec 2017 by 2 episodes of pneumonia. The girl was treated with salbutamol [albuterol] and antibiotics. She also underwent autologous stem cell rescue (ASCR) using thiotepa, cyclophosphamide, carboplatin, etoposide and melphalan. Various toxicities: 3 case reports However, the ASCR was complicated by cough, wheezing and In a case series, three patients (2 boys and 1 girl) aged hypoxia. Her respiratory distress worsened, following which, between 32 months 4 years were described, who developed she required transfer to the ICU. She then received treatment various toxicities following the therapy with various drugs [ not with methylprednisolone. Consequently, her hypoxia all dosages and times to reactions onsets stated; routes not resolved. She was then discharged on daily inhaled steroids stated ]. Patient 1: The 32-month-old boy, who had asthma, and salbutamol as needed. During her second ASCR, she was was intermittently treated with salbutamol [albuterol] and placed on prophylactic steroids 2 days before admission. She budesonide. He was eventually diagnosed with again required transfer to the ICU on day 9 after the ASCR due neuroblastoma. He received 6 cycles of chemotherapy with to respiratory distress. Thereafter, she received cyclophosphamide, topotecan, cisplatin, etoposide, vincristine methylprednisolone treatment. She
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera